Objectives To identify the prevalence of GJB2 (Cx 26)and GJB6 (Cx 30) mutations in hearing impaired individuals from Western and South India.
Abstract
Objectives To identify the prevalence of GJB2 (Cx 26)and GJB6 (Cx 30) mutations in hearing impaired individuals from Western and South India.
Study design Cross-sectional study.
Methods Families with hearing impaired individuals (prelingual, non-syndromic, sensori-neural hearing loss) were enrolled and genomic DNA was extracted. Primers were designed for amplifying the coding and non-coding Probands heterozygous or negative for Cx 26 mutations were further analyzed for the 342Kb deletion encompassing D13S1830 microsatellite marker on Cx 30.
Results Two hundred and eighty-eight patients were enrolled in the study and 116 (40.3%) were diagnosed to have mutations in the coding exon 2 of Cx 26 gene. Fiftyfour (18.8%) probands were found to have mutations in both the alleles while the remaining 62 (21.5%) were heterozygous for Cx 26 mutations. W24X, and W77X were deafness was similar in both consanguineous and nonconsanguineous families (33% and 34.9% respectively).
Mutations in the non-coding exon 1 and intron 1 as well as the 342 kb deletion involving D13S1830 marker on Cx 30 were ruled out in two hundred and thirty-four deaf individuals carrying none or only one mutation in the exon 2 of Cx 26 gene.
Conclusion Cx 30 mutations do not contribute to the autosomal recessive non-syndromic hearing loss (NSHL) in the Indian population. Homozygous Cx26 mutations account only for about 1/5th (18.8%) of autosomal recessive non-syndromic hearing implying the need to explore other contributory loci.
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Introduction
Prelingual hearing loss is a serious concern because it affects development of language and may interfere with development of social and cognitive skills. Prelingual deafness occurs with a frequency of 1 in 1000 live births, of which about 50% is reported to be genetic in origin [1] . Families with affected individuals are often anxious about recurrence of hearing loss in their future pregnancies as treatment and rehabilitation options are limited and expensive. Prenatal diagnosis for such families is possible only through genetic testing of fetal DNA as this condition cannot be diagnosed by any other non-invasive tests such as ultrasound. Genetic basis of hearing loss is highly complex with evidence of tremendous heterogeneity and variable autosomal dominant and recessive deafness (http://webhost. ua.ac.be/hhh), apart from sex-linked and mitochondrial deafness. However, mutations in 2 genes Cx 26 and Cx 30 deafness in different populations all over the world [1] . In addition, the spectrum of mutations in Cx 26 gene is known to differ in different ethnic populations.
Indian data on the genetics of non-syndromic hearing NSHL is limited and is based on several small studies except a recent larger study by Mani et al. [2] . India is a huge obtained from one part of the country to other regions. We investigated the prevalence of Cx 26 and Cx 30 mutations in hearing impaired individuals from Western and South India. Here we discuss the results of our study as well as the need for further studying the genetic basis of hearing loss in Indians. This study adds to the existing database of mutational spectrum of Cx 26 gene in different regions from India and thus may aid in the genetic testing and prenatal diagnosis in various target families.
Materials and methods

Enrolment of subjects
Families with hearing impaired individuals were contacted through the special schools and social organizations for the deaf and Cochlear Implant centers from various cities of Maharashtra, Western India and from Chennai, Tamil Nadu, Southern India. Preceding the enrolment and sample collection, the research team conducted special sessions to create awareness regarding the hereditary component of deafness.
Inclusion criteria
Individuals with congenital, bilateral, severe to profound sensori-neural deafness without any other dysmorphic features or systemic affection and without any known etiology for deafness were included in the study. The degree and/or Brain Stem Evoked Response Audiometry (BERA). A structured questionnaire was used to obtain details of hearing disability including age of diagnosis, type, severity, rehabilitation and educational history etc., along with the three-generation family history, wherever available.
Procedure
Five milliliter whole blood was collected in EDTA from the affected individuals and their family members after obtaining appropriate informed consent. Genomic DNA was extracted from peripheral blood leucocytes according to standard protocols. Primers were designed for amplifying the coding and non-coding exons of the Cx 26 gene individually on both strands using ABI Genetic Analyzer 3730 and analyzed using Autoassembler software. Mutaparents to aid in future prenatal diagnosis and genetic counseling. Probands heterozygous or negative for Cx 26 mutations were further analyzed for the 342Kb deletion encompassing D13S1830 microsatellite marker on Cx deletion in Cx 30 gene was analyzed using a multiplex PCR approach. The study protocol was approved by ethics committees of both collaborating institutes.
Results
A total of 288 unrelated families comprising of 183 male and 105 female probands were enrolled in the study. Nearly 1/3rd of the families reported consanguineous marriage (106/288; 36.8%). However, the prevalence of familial deafness (more than one individual affected), was similar in both consanguineous and non-consanguineous families (33% and 34.9% respectively) suggesting possible heterogeneity in pattern of inheritance as well as possibility of high carrier frequency of Cx 26 mutations in this study population.
in 116 out of 288 families (40.3%) screened. Of these, 54 (18.8%) probands were found to have mutations in both the alleles while the remaining 62 (21.5%) were heterozygous for Cx 26 mutations. Amongst the 54 individuals with biallelic Cx 26 mutations, 48 were homozygous while six were compound heterozygotes for two different mutations in the Cx 26 gene. W24X and W77X were the common (56/288) of deaf individuals, followed by W77X in 17/288 (5.9%) patients. R127H variant was present in -41 probands that included 3 homozygotes, 36 heterozygotes and 2 compound heterozygotes with W24X mutation. Other mutations including M1V, V27I, and 35insG were found in one proband each. Nearly half of the probands (26/54; 48.1%) with bi-allelic Cx 26 mutations were born to non-consanguineous parents and an equal proportion had consanguineous parents.
Two hundred and thirty four deaf individuals carrying none or only one mutation in the exon two of Cx 26 gene were analyzed for mutations in the non-coding exon one and were then screened for the 342 kb deletion involving deletion) followed by sequencing of the complete gene.
in Cx 30 gene in any of these families including those heterozygous for a Cx 26 mutation.
